MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
38.50
-0.03 (-0.08%)
Jul 9, 2026, 11:06 AM EDT - Market open
MapLight Therapeutics Employees
MapLight Therapeutics had 133 employees as of December 31, 2025. The number of employees increased by 70 or 111.11% compared to the previous year.
Employees
133
Change
70
Growth
111.11%
Revenue / Employee
n/a
Profits / Employee
-$1,499,850
Market Cap
1.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 133 | 30 | 29.13% |
| Sep 30, 2025 | 114 | - | - |
| Jun 30, 2025 | 109 | 35 | 47.30% |
| Mar 31, 2025 | 103 | 29 | 39.19% |
| Mar 31, 2024 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Immunocore Holdings | 524 |
| Vir Biotechnology | 367 |
| UroGen Pharma | 298 |
| Zenas BioPharma | 167 |
| Innoviva | 159 |
| Maze Therapeutics | 141 |
| Septerna | 130 |
MPLT News
- 14 days ago - MapLight Therapeutics initiated with a Strong Buy at Raymond James - TheFly
- 15 days ago - MapLight Therapeutics Announces Changes to Board of Directors - GlobeNewsWire
- 15 days ago - MapLight Therapeutics price target lowered to $40 from $43 at Craig-Hallum - TheFly
- 17 days ago - MapLight Therapeutics Transcript: Study result - Transcripts
- 17 days ago - MapLight Therapeutics Press release: Study result - Filings
- 17 days ago - MapLight Therapeutics Slides: Study result - Filings
- 17 days ago - MapLight Therapeutics announces IRIS trial misses primary endpoint - TheFly
- 17 days ago - MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder - GlobeNewsWire